*Women's Health Initiatives Maternal and Menopause
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $3,000,000 to $7,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Points of contact
-
- CDRH Acquisition Liaison cdhracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring administrative management and general management consulting services focused on women's health initiatives related to maternal and menopause medical devices, with an estimated solicitation release on January 1, 2027, and award anticipated September 1, 2027. The scope includes two landscape analyses, two market analyses, and two strategic plans addressing gaps and opportunities in maternal and menopause medical devices.
The estimated award value ranges from $3 million to $7 million. This is a new requirement with no set-aside applied. Interested parties should direct inquiries to the FDA's Center for Devices and Radiological Health acquisitions mailbox at cdhracquisitions@fda.hhs.gov.
Forecast text
2 landscape analyses, 2 market analyses, 2 strategic plans for gaps and opportunities with maternal and menopause medical devices
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast